Fig. 1From: CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s diseaseA summary of major study measures in trial participants. 24HC, 24-hydroxycholesterol; Baseline, baseline visit; Chol, cholesterol; Aβ40 and Aβ42, amyloid β peptides 40 and 42; pTau, phosphorylated tau; tTau, total tau; MoCA, the Montreal Cognitive Assessment; week 8, week 20, and week 22 in-clinic visitsBack to article page